Chromosomal analysis of single sperm cells from infertile couples with severe oligoteratozoospermia: A cross-sectional prospective study

• DOI: 10.1371/journal.pone.0303350
• Publication Date: 2024-06-14T17:33:38Z
• Authors: Supitcha Sassanar...; Sudaporn Chamnankran; Artitaya Singwongsa; Matchuporn Sukpra...; Chonthicha Satirapod
• Keywords: Male; Adult; Science; Noninvasive Prenatal Testing; Population; Chromosome; Gene; Global Trends in Infertility and Reproductive Technologies; Aneuploidy Screening; Semen; Pregnancy; Health Sciences; Genetics; Humans; Prospective Studies; Andrology; Biology; Internal medicine; Infertility, Male; Male infertility; Fetal DNA Analysis; Q; R; Fertility Preservation in Cancer Patients; Public Health, Environmental and Occupational Health; High-Throughput Nucleotide Sequencing; Prenatal Aneuploidy Diagnosis and Screening Techniques; Oligospermia; Odds ratio; Aneuploidy; Assisted reproductive technology; Spermatozoa; Sperm; Semen Analysis; Cross-Sectional Studies; Environmental health; Reproductive Medicine; Gynecology; Karyotyping; Infertility; FOS: Biological sciences; Pediatrics, Perinatology and Child Health; Semen analysis; Medicine; Single-Cell Analysis; Research Article

In this cross-sectional prospective study, advanced next-generation sequencing technology was used to compare the molecular karyotyping of individual human sperm cells in infertile couples with severe oligoteratozoospermia (i.e., low sperm count and motility) to those of infertile couples with normal semen. Fourteen infertile couples who were patients at Ramathibodi Hospital in Bangkok, Thailand, were recruited from January to November 2023, and they were categorized into two groups based on semen analysis results. The study group comprised couples with severe oligoteratozoospermia, whereas the control group exhibited normal semen. Individual sperm cells from the semen samples were isolated by the micromanipulation technique for subsequent whole-genome amplification and next-generation sequencing, where the primary outcome was the aneuploidy rate. Seventy individual sperm cells were isolated with a 90% success rate for amplification. The next-generation sequencing results showed that the aneuploidy rate was 25%–75%, with a mean of 48.28% in the study group. In contrast, the control group exhibited aneuploidy rates of 0–75%, with a mean of 15.15%. The difference between the two groups was statistically significant (odds ratio: 5.8, 95% confidence interval: 1.30–26.03). Sperm cells of the study group showed a threefold higher aneuploidy rate than those in the control group, even though the sperm cells were selected by micromanipulation for their normal morphology. Comprehensive counseling is recommended to address elevated aneuploidy rates that potentially surpass those of the general infertile population. Guidance on preimplantation genetic testing is also recommended to ensure the transfer of embryos with normal chromosomes.